Mr. Samikoglu is a public and private investor, entrepreneur and a former investment banker. Prior to Biosplice, he was the Co-Founder, Portfolio Manager and a Partner of Greywolf Capital Management LP, a New York-based investment fund managing capital in different strategies. Prior to forming Greywolf, he was the Director of Research and a Portfolio Manager of Goldman Sachs’ Special Situations Investing Group. Mr. Samikoglu began his career at Goldman, Sachs & Co. where he spent nine years, both as a proprietary investor and as an investment banker.

Mr. Samikoglu received his MBA from Harvard Business School and his BA in Economics from Hamilton College.

Dr. Kibar is an entrepreneur and an inventor, with numerous successful start-ups under his belt. He was the Scientific Founder of Genoptix (an oncology diagnostics company), which went public in 2007 (NASDAQ: GXDX) and was later acquired by Novartis in 2011. Dr. Kibar was also a Co-Founder of E-Tenna, whose assets relating to wireless antennas were acquired by Titan and assets relating to thermal management of microprocessors by Intel. He was a Vice President at Pequot Capital's venture capital and private equity team.

Dr. Kibar received his MS and PhD, specializing in Biophotonics and Optoelectronics, from University of California, San Diego, a BS in Electrical Engineering from Caltech and a BA in Mathematical Economics from Pomona College.

Dr. Yazici is an internationally-renowned rheumatologist, researcher, and an expert in clinical trial design and management. He is a Clinical Associate Professor of Medicine at New York University School of Medicine and the Director of Behcet Syndrome Center, the largest center for Behcet syndrome in the US. He has published more than 250 medical papers and book chapters, and has given numerous national and international presentations.

Dr. Yazici completed his Fellowship in Rheumatology at the Hospital for Special Surgery of Weill Medical College of Cornell University in New York and Residency in Internal Medicine at Creighton University in Nebraska. Dr. Yazici received his medical degree from Istanbul University.

Mr. Horsley has two decades of experience building businesses as a private equity investor and entrepreneur. Most recently, he was a Partner and a founding member of Intervale Capital, a Boston-based private equity firm with multiple funds under management. Previously, Mr. Horsley worked as a Principal at Watermill Group, a generalist private equity firm, and as an investment banker at Morgan Stanley in New York and Frankfurt.

Mr. Horsley has an MBA from Harvard Business School and an AB in Psychology and English from Harvard College.

Mr. Bulcao has more than 15 years of experience advising life sciences and other corporate clients on a variety of legal matters. He began his legal career at Simpson Thacher & Barlett LLP in New York following a federal judicial clerkship with the Honorable Barbara M.G. Lynn of the United States District Court for the Northern District of Texas. He subsequently joined the Wall Street litigation boutique Schindler Cohen & Hochman LLP.

Mr. Bulcao received his JD from New York University School of Law and his BA in English Literature and Language from the University of Virginia.